ClinicalTrialsFinder

Multiple Myeloma, Refractory to Standard Treatment Clinical Trials in Jerusalem

1 recruitingJerusalem, Israel

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis
Polina Stepensky180 enrolled1 locationNCT06971380